Medicinal product name Seretide 25/125 microgram/dose pressurised inhalation, suspension
Pharmaceutical form Pressurised inhalation, suspension
Strength 25/125 μg/dose 
Information from the MAH on shortages Not available
predicted availability date: May 31, 2024
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
01-0452-01N120 Is available
Legal status Rx Prescription (Pr.)
Package leafletMS Word document 29-03-2022
Summary of product characteristicsMS Word document 29-03-2022
ATC code R03AK06 Drugs for obstructive airway diseases

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(82 containers)
predicted availability date: May 31, 2024
Tamro, Oribalt Rīga N120
(25 µg/125 µg/dose)
Aluminium 28.59  01-0452-01 Labelling text Labelling text Mar 29, 2022

Registration information

Marketing authorisation No. 01-0452
Date of authorisation Dec 19, 2001
Marketing authorisation holder, country GlaxoSmithKline Trading Services Limited, Ireland